Does LEVOSIMENDAN Cause Pulmonary hypertension? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Pulmonary hypertension have been filed in association with LEVOSIMENDAN. This represents 7.1% of all adverse event reports for LEVOSIMENDAN.
13
Reports of Pulmonary hypertension with LEVOSIMENDAN
7.1%
of all LEVOSIMENDAN reports
0
Deaths
11
Hospitalizations
How Dangerous Is Pulmonary hypertension From LEVOSIMENDAN?
Of the 13 reports, 11 (84.6%) required hospitalization, and 2 (15.4%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOSIMENDAN. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOSIMENDAN Cause?
Drug ineffective (64)
Cardiac failure (37)
Hypotension (37)
Off label use (28)
Respiratory failure (27)
Constipation (16)
Hypothyroidism (16)
Ejection fraction decreased (15)
Jugular vein distension (14)
Condition aggravated (12)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
Which LEVOSIMENDAN Alternatives Have Lower Pulmonary hypertension Risk?
LEVOSIMENDAN vs LEVOSULPIRIDE
LEVOSIMENDAN vs LEVOTHYROXINE
LEVOSIMENDAN vs LEVOTHYROXINE\LEVOTHYROXINE
LEVOSIMENDAN vs LEVOTHYROXINE\LIOTHYRONINE
LEVOSIMENDAN vs LEVOXYL